M&T Bank Corp lessened its holdings in Monsanto (NYSE:MON) by 1.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 134,898 shares of the basic materials company’s stock after selling 1,753 shares during the period. M&T Bank Corp’s holdings in Monsanto were worth $15,755,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in MON. Americafirst Capital Management LLC bought a new position in Monsanto in the 3rd quarter valued at $148,000. S&CO Inc. bought a new position in Monsanto in the 3rd quarter valued at $216,000. McKinley Carter Wealth Services Inc. bought a new position in Monsanto in the 4th quarter valued at $218,000. Corundum Group Inc. bought a new position in Monsanto in the 3rd quarter valued at $228,000. Finally, Intact Investment Management Inc. bought a new position in Monsanto in the 3rd quarter valued at $239,000. Hedge funds and other institutional investors own 75.62% of the company’s stock.

In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the firm’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the transaction, the executive vice president now owns 56,743 shares in the company, valued at approximately $6,772,277.05. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.79% of the stock is owned by company insiders.

Monsanto (MON) opened at $118.64 on Friday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28. The firm has a market capitalization of $52,296.63, a price-to-earnings ratio of 20.71, a PEG ratio of 1.70 and a beta of 1.01. Monsanto has a 12 month low of $106.97 and a 12 month high of $123.15.

Monsanto (NYSE:MON) last posted its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.01). The firm had revenue of $2.66 billion for the quarter, compared to the consensus estimate of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm’s revenue was up .3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.21 EPS. research analysts forecast that Monsanto will post 5.76 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, April 6th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Thursday, April 5th. This represents a $2.16 annualized dividend and a yield of 1.82%. Monsanto’s dividend payout ratio is currently 39.85%.

A number of research analysts have issued reports on the company. Royal Bank of Canada restated a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Wednesday, November 15th. Deutsche Bank restated a “buy” rating on shares of Monsanto in a research note on Tuesday, January 16th. Wells Fargo & Co restated a “market perform” rating and issued a $128.00 price objective (up previously from $118.00) on shares of Monsanto in a research note on Wednesday, January 17th. Finally, Zacks Investment Research downgraded Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. Eleven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $127.30.

WARNING: This report was published by Watch List News and is owned by of Watch List News. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.watchlistnews.com/monsanto-mon-holdings-cut-by-mt-bank-corp/1859362.html.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.